Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron in Pediatric Overactive Bladder
NCT04641975Phase 3Terminated
- Sponsor
- Astellas Pharma
- Start
- Mar 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Mar 2021; status: terminated.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04641975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04641975.